Table 1.
Pathway | Cancer | circRNA | Gene of Origin | Interactions | Effect | Reference |
---|---|---|---|---|---|---|
VEGF | Bladder cancer | circ-MYLK | MYLK | miR-29a-3p/VEGFA | Promotes cancer progression | [43] |
Cervical cancer | circ_0023404 | RNF121 | miR-5047/VEGFA | Promotes cancer metastasis and chemoresistance | [46] | |
Colorectal cancer | circ_001971 (circ_0001060) 1 |
UXS1 | miR-29c-3p/VEGFA | Promotes cancer growth, angiogenesis, and metastasis | [47] | |
Renal cell carcinoma | circ-MYLK | MYLK | miR-513a-5p/VEGFC | Promotes cancer growth and metastasis | [44] | |
Pancreatic cancer | circ-NFIB1 (circ_0086375) 1 |
NFIB | miR-486-5p/ PIK3R1/VEGFC |
Inhibits lymphangiogenesis and lymphatic metastasis, suppresses cancer progression | [45] | |
WNT/β-catenin | Glioblastoma multiforme | circ_0043278 | TADA2A | miR-638 | Promotes cancer progression | [50] |
Osteosarcoma | circ-MYO10 | MYO10 | miR-370-3p/RUVBL1 | Regulates chromatin remodeling; promotes cancer progression | [51] | |
circ_0002052 | PAPPA | miR-1205/APC2 | Suppresses cancer progression | [52] | ||
Papillary thyroid cancer | circ_102171 | SMURF2 | CTNNBIP1 | Promotes cancer progression | [53] | |
circ-ITCH | ITCH | miR-22-3p/CBL | Suppresses cancer progression | [54] | ||
Breast cancer | circ-ITCH | ITCH | miR-214-3p/ITCH, miR-17-5p/ITCH |
Suppresses cancer progression | [55] | |
Endometrial | circ_0002577 | WDR26 | miR-197-3p/CTNND1 | Promotes cancer progression | [56] | |
Esophageal squamous cell carcinoma | circ-GSK3B | GSK3B | - | Promotes metastasis | [57] | |
Colorectal cancer | circ_100290 | - | miR-516b-5p/FZD4 | Promotes cancer progression | [58] | |
circ_0009361 | GNB1 | miR-582-3p/APC2 | Suppresses cancer progression | [59] | ||
Gastric cancer | circ-HECTD1 | HECTD1 | miR-1256 | Promotes glutaminolysis and cancer progression | [60] | |
circ-HIPK3 | HIPK3 | WNT1, TCF4, β-catenin |
Promotes cancer progression | [20] | ||
circ-FGD4 | FGD4 | miR-532-3p/APC | Suppresses cancer progression | [61] | ||
circ-REPS2 | REPS2 | miR-558/RUNX3 | [62] | |||
Hepatocellular carcinoma | circ-ZFR | ZFR | miR-3619-5p/β-catenin | Promotes cancer progression | [63] | |
circ_0067934 | PRKCI | miR-1324/FZD5 | Promotes tumor growth and metastasis | [64] | ||
Lung cancer | circ_0006427 | BCAR3 | miR-6783-3p/DKK1 | Suppresses cancer progression | [65] | |
Non-small cell lung cancer | circ_000984 (circ_0001724) 1 |
CDK6 | - | Promotes cell proliferation and metastasis | [66] | |
Retinoblastoma | circ-TET1 | TET1 | miR-492, miR-494-3p | Suppresses cancer progression | [67] |
1 Names in parentheses denote the circRNA ID or alias, as listed on circBase.